NCT02143466 AZD9291 in Combination With Ascending Doses of Novel Therapeutics Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02142556 The Efficacy and Safety of Quetiapine XR in Patients With Schizophrenia Switched From Other Antipsychotics Status COMPLETED Phase PHASE3
NCT02141347 Ph1 to Assess Safety, Tolerability of Tremelimumab/ Tremelimumab+MEDI4736 in Japanese Solid Malignancies/ Mesothelioma Status COMPLETED Phase PHASE1
NCT02138916 Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History Status COMPLETED Phase PHASE3
NCT02137837 S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer Status TERMINATED Phase PHASE3
NCT02132286 Serotonin Transporter Genetic Variation and Amygdala Responses to Antidepressant Medications in Major Depression Status COMPLETED Phase PHASE4
NCT02130882 Study to Evaluate Safety and Efficacy of Benralizumab in Subjects With Hypereosinophilic Syndrome Status UNKNOWN Phase PHASE2/PHASE3
NCT02128529 Epidemiology of Chronic Bronchitis in Patients With Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase N/A
NCT02127710 A Phase II Trial to Evaluate the Efficacy of AZD6094 (HMPL-504) in Patients With Papillary Renal Cell Carcinoma (PRCC) Status COMPLETED Phase PHASE2
NCT02126514 A Phase I, Open-Label, Single-Center Study to Assess the Absorption, Metabolism, and Excretion of [14C]-AZD3293 Status COMPLETED Phase PHASE1
NCT02125461 A Global Study to Assess the Effects of MEDI4736 Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT02121990 Dose-Escalation Study of Intraperitoneal (IP) Cisplatin, IV/IP Paclitaxel, IV Bevacizumab, and Oral Olaparib for Newly Diagnosed Ovarian, Primary Peritoneal, and Fallopian Tube Cancer Status COMPLETED Phase PHASE1
NCT02121639 Open Label Phase I/Randomised,Double Blind Phase II Study in mCRPC of AZD5363 In Combination With DP Chemotherapy Status COMPLETED Phase PHASE1/PHASE2
NCT02121288 Adenosine-induced Myocardial Blood Flow in Peripheral Artery Disease Patients Status WITHDRAWN Phase PHASE4
NCT02117167 SAFIR02_Lung - Efficacy of Targeted Drugs Guided by Genomic Profiles in Metastatic NSCLC Patients Status COMPLETED Phase PHASE2
NCT02110303 DIAMOND - Dual Antiplatelet Therapy to Reduce Myocardial Injury Status COMPLETED Phase PHASE2/PHASE3
NCT02104817 Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia Status COMPLETED Phase PHASE3
NCT02104804 Evaluate the Efficacy and Safety of Saxagliptin Added to Insulin Monotherapy or to Insulin Combined With Metformin in Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control Status COMPLETED Phase PHASE3
NCT02100332 A Cross Sectional Disease/Condition Focused Observational Study on Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase N/A